At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 26 enrolled
Drug / intervention
Methylphenidate +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of Methylphenidate for Management of Long-Term Attention Problems After Pediatric Traumatic Brain Injury (TBI)
Children's Hospital Medical Center, Cincinnati·interventional·Posted Sep 2, 2013·Updated Jun 4, 2020
In Brief
A Phase 4 clinical trial evaluating Methylphenidate and Placebo for Traumatic Brain Injury and 2 related conditions. Completed, enrolled 26 participants across 1 site.
Detailed Summary
Traumatic Brain Injury (TBI) - methylphenidate treatment
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTraumatic Brain Injury, TBI, ADHD
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedSep 2013
Enrollment StartNov 2013
Primary CompletionAug 2016
TodayJul 2026
First PostedSep 2, 2013
Enrollment StartNov 1, 2013
Primary CompletionAug 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 12.8 years ago
Interventions
Methylphenidatedrug
Placebodrug